Related Experiment Video
Updated: Mar 18, 2026

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
Published on: August 25, 2014
Serotonin and poor neonatal adaptation after antidepressant exposure in utero
Noera Kieviet1, Vera van Keulen1, Peter Marinus van de Ven2
11Department of Pediatrics,Psychiatry Obstetric Pediatric Expert Center,OLVG West Hospital,Amsterdam,The Netherlands.
Insights
Infants exposed to selective serotonin reuptake inhibitors (SSRIs) during pregnancy may experience poor neonatal adaptation. This study found altered neonatal 5-hydroxyindoleacetic acid (5-HIAA) levels in exposed infants with poor adaptation, suggesting a role for serotonin metabolism.
Area of Science:
- Neonatal adaptation
- Neuroscience
- Pharmacology
Background:
- Infants exposed to selective antidepressants (SADs) in utero face risks of poor neonatal adaptation (PNA).
- The non-specific symptoms and unknown etiology of PNA complicate diagnosis.
- Serotonin metabolism is investigated as a potential factor in PNA's development.
Purpose of the Study:
- To investigate the role of serotonin metabolism in the etiology of poor neonatal adaptation (PNA) in infants exposed to selective antidepressants (SADs) in utero.
- To compare neonatal urinary 5-hydroxyindoleacetic acid (5-HIAA) levels between SAD-exposed infants with and without PNA, and control infants.
Main Methods:
- A controlled study included 63 SAD-exposed infants and 126 non-exposed controls over 3 days postpartum.
- Neonatal urinary 5-hydroxyindoleacetic acid (5-HIAA) levels were measured.
- Infants were categorized into: SAD-exposed with PNA, SAD-exposed without PNA, and control infants.
Main Results:
- The course of 5-HIAA levels differed significantly between infants with and without PNA (p≤0.001).
- Infants with PNA exhibited higher 5-HIAA levels on day 1 (2.42 mmol/mol, p=0.001).
- Maternal psychological distress was found to modify the relationship between SAD exposure and PNA outcomes.
Conclusions:
- A transient disturbance in the neonatal serotonergic system may contribute to the etiology of PNA.
- Maternal psychological distress appears to be another significant factor influencing PNA.
Objective:
Infants exposed to selective antidepressants (SADs) in utero are at risk to develop poor neonatal adaptation (PNA) postpartum. As symptoms are non-specific and the aetiology of PNA is unknown, the diagnostic process is hampered. We hypothesised that the serotonin metabolism plays a role in the aetiology of PNA.
Methods:
In this controlled study, infants admitted postpartum from February 2012 to August 2013 were included and followed for 3 days. Infants exposed to SADs during at least the last 2 weeks of fetal life were included in the patient group (n=63). Infants not exposed to psychotropic medication and admitted postpartum for another reason were included in the control group (n=126). The neonatal urinary 5-hydroxyindoleacetid acid (5-HIAA) levels of SAD-exposed infants who developed PNA, SAD-exposed infants who did not develop PNA and control infants were compared.
Results:
The course of the 5-HIAA levels over the first 3 days postpartum differed between infants with and without PNA (p≤0.001) with higher 5-HIAA levels in infants with PNA on day 1 (2.42 mmol/mol, p=0.001). Presence of maternal psychological distress modified this relationship.
Conclusions:
A transient disturbance of the neonatal serotonergic system may play a role in the aetiology of PNA. Other factors, including the presence of maternal psychological distress, also seem to play a role.
Related Concept Videos
Antidepressant Drugs: MAOIs and Other Agents
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
Antidepressant Drugs: Overview
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
A study on guinea pigs examined the...
G-protein Coupled Receptors
Socioemotional Development during Infancy
Primary Temperament Types

